LENSAR Announces Poster Presentations at the American Academy of Ophthalmology

Rhea-AI Summary

LENSAR, Inc. (NASDAQ: LNSR) announced two poster presentations accepted for the American Academy of Ophthalmology (AAO) Annual Meeting, scheduled for November 12-15, 2021. The presentations highlight the use of LENSAR's femtosecond laser technology in improving astigmatic outcomes during cataract surgery. The topics are:

• Femtosecond Laser Image Guided Corneal Arcuate Incisions for Managing Mild Keratometric Astigmatism in Cataract Surgery
• Toric IOL alignment with femtosecond laser capsular marks confirmed by intraoperative aberrometry

This showcases LENSAR's commitment to enhancing visual outcomes in cataract treatment.

Positive

• Two poster presentations accepted at the prestigious AAO Annual Meeting, increasing visibility.
• Focus on advanced femtosecond laser technology that could improve surgical outcomes.

Negative

• None.

Demonstrates LENSAR Laser’s Ability to Guide Improved Astigmatic Outcomes for Patients

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that two posters have been accepted for virtual presentation at the Annual Meeting of the American Academy of Ophthalmology (AAO) being held November 12-15, 2021.

The titled presentations will be available on the AAO meeting portal starting on November 12, 2021:

Femtosecond Laser Image Guided Corneal Arcuate Incisions for Managing Mild Keratometric Astigmatism in Cataract Surgery, by Denise Visco, M.D.

Toric IOL alignment with femtosecond laser capsular marks confirmed by intraoperative aberrometry, by Dee Stephenson, M.D.

About LENSAR

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211112005371/en/

Thomas R. Staab, II, CFO

ir.contact@lensar.com

Lee Roth / Cameron Radinovic

Burns McClellan for LENSAR

lroth@burnsmc.com / cradinovic@burnsmc.com

Source: LENSAR, Inc.

FAQ

What are the LENSAR (LNSR) poster presentations about?

LENSAR's presentations focus on improving astigmatic outcomes during cataract surgery using femtosecond laser technology.

When is the AAO Annual Meeting where LENSAR will present?

The AAO Annual Meeting is scheduled from November 12-15, 2021.

How does LENSAR's technology benefit cataract surgery?

LENSAR's femtosecond laser technology aims to improve visual outcomes and surgical efficiency.

What topics will LENSAR present at the AAO meeting?

The topics include managing astigmatism with femtosecond lasers and toric IOL alignment with capsular marks.